1-5 of 5
Richard Davis
Close
Sort by
Journal Articles

Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma

Florian Scherer, MD, David M. Kurtz, MD, Aaron M Newman, PhD, Mohammad Shahrokh Esfahani, PhD, Alexander Craig, MPhil, Henning Stehr, PhD, Alexander F. Lovejoy, PhD, Jake J. Chabon, Chih Long Liu, PhD, Li Zhou, Cynthia Glover, Brendan C. Visser, MD, George Poultsides, MD, Ranjana H Advani, MD, Lauren S Maeda, MD, Neel K. Gupta, MD, Ronald Levy, MD, Robert S. Ohgami, MD PhD, Eric Richard Davis, MD, Gianluca Gaidano, MD PhD, Christian A. Kunder, MD PhD, Davide Rossi, Jason R. Westin, MD, Maximilian Diehn, MD PhD, Ash A Alizadeh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1089.
https://doi.org/10.1182/blood.V128.22.1089.1089
Published: 2016
Journal Articles

High Risk Diffuse Large B Cell Lymphoma: A Comparison of Aggressive Subtypes Treated with Dose Adjusted Chemotherapy-the University of Texas MD Anderson Experience

Vishwanath Sathyanarayanan, MD, Yasuhiro Oki, MD, Amir K Issa, MD, Mohamed Amin Ahmed, MD, Mansoor Noorani, Michelle A Fanale, MD, Fredrick B. Hagemeister, MD, Sattva S. Neelapu, MD, Loretta J. Nastoupil, MD, Nathan Fowler, MD, Francesco Turturro, MD, Eric Richard Davis, MD, Alma Rodriguez, MD, Michael Wang, MD, Lei Feng, MS, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Chelsea C Pinnix, MD PhD, Luis E. Fayad, MD, Jason R. Westin, MD
Journal: Blood
Blood (2016) 128 (22): 106.
https://doi.org/10.1182/blood.V128.22.106.106
Published: 2016
Journal Articles

Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I Results

Jason R. Westin, MD, Vishwanath Sathyanarayanan, MD, Luis E. Fayad, MD, Loretta J. Nastoupil, MD, Francesco Turturro, MD, Fredrick B. Hagemeister, MD, Kristin A. Simar, RN, ANP-BC, Ken H. Young, MD PhD, Timothy J. McDonnell, MD PhD, Hubert H Chuang, MD PhD, Fazal Kamil, Lei Feng, MS, Eric Richard Davis, MD, Sattva S. Neelapu, MD, Yasuhiro Oki, MD
Journal: Blood
Blood (2016) 128 (22): 5395.
https://doi.org/10.1182/blood.V128.22.5395.5395
Published: 2016
Journal Articles

BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825, Causes Sustained Degradation of BRD4 and Modulation of Chemokine Receptors, Cell Adhesion and Metabolic Targets in Leukemia Resulting in Profound Anti-Leukemic Effects

Sujan Piya, PhD, Seemana Bhattacharya, PhD, Hong Mu, MD PhD, Philip L Lorenzi, PhD, Teresa McQueen, MS, Eric Richard Davis, MD, Vivian Ruvolo, MS, Natalia Baran, PhD, Yimin Qian, PhD, Craig Crews, PhD, Hagop M. Kantarjian, MD, Michael Andreeff, MD PhD, Gautam Borthakur, MD
Journal: Blood
Blood (2016) 128 (22): 748.
https://doi.org/10.1182/blood.V128.22.748.748
Published: 2016
Journal Articles

Non-Stereotypic Follicular Lymphoma B-Cell Receptors Recognize Vimentin as a Shared Autoantigen

Soung-Chul Cha, Hong Qin, Shivichakravarthy Kannan, Seema Rawal, PhD, Weiguo Wu, Juliana Ong, Jinsong Wei, Benjamin Kwak, Sang Kim, Michael Popescu, Daniel Paick, Richard Davis, Larry Kwak, Sattva S. Neelapu
Journal: Blood
Blood (2010) 116 (21): 139.
https://doi.org/10.1182/blood.V116.21.139.139
Published: 2010